|
- Roche - Doing now what patients need next
Roche is a leader and innovator in addressing antimicrobial resistance (AMR) We are investing in new antibiotics and diagnostics and working with partners to bring hope through breakthroughs
- About Roche
Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
- Roche Pharmaceuticals
Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients It combines cutting-edge research at in the US in Japan and over 250 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations
- Our History - Roche
Roche was founded in Switzerland in 1896 as one of the first companies specifically set up to manufacture scientifically researched pharmaceuticals Already at an early stage the company expanded to other countries such as Italy and Germany
- Careers at Roche | Roche jobs
Roche is at the forefront of technological advancements in healthcare Elevate your career with us by joining our tech team Whether you're a software developer, data analyst, or IT expert, Roche provides a platform for you to innovate and make a lasting impact on global healthcare
- Roche Diagnostics
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases
- Diagnostic solutions - Roche
Roche Diagnostics About Roche We combine science, data and insights to transform the way diseases can be prevented, diagnosed and monitored Our medical assays, digital solutions and services help people live healthier lives
- Roche | Product Development Portfolio
Access Roche's financial and non-financial reports for the latest updates on Roche's performance Genentech Pipeline Our R D activities are focused on applying excellent science to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics
|
|
|